Long-term outcomes of TAVI in patients with cancer: insights into early and late mortality trends

Back

Delegates Premium Access

Long-term outcomes of TAVI in patients with cancer: insights into early and late mortality trends

Session: Decoding cardiac biomarkers and coronary interventions in patients with cancer

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Doctor I. Nardi Agmon (Petah Tikva, IL)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Inbar Nardi Agmon

Rabin Medical Center, Petah Tikva (Israel)

1 presentation

0 follower

5 more presentations in this session

Revascularization and mortality in ischemic heart disease among children, adolescents and young adults with cancer: Insights from the Rebuc Study

Speaker: Doctor J. Sodling (Norrkoping, SE)

Access

Abstract

Slides

Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.

Speaker: Doctor L. Spadafora (Latina, IT)

Access

Abstract

Slides

Details of elevated troponin levels and clinical outcomes following immune checkpoint inhibitor treatment

Speaker: Doctor Y. Shibutani (Kashiwa, JP)

Access

Abstract

Slides

Cardiac troponins and anthracycline cardiotoxicity: a sub study of the PROACT trial; are all assays made equal?

Speaker: Doctor G. Gilbert (Middlesbrough, GB)

Access

Abstract

Slides

Tracking cardiac troponin dynamics in patients treated with immune checkpoint inhibitors

Speaker: Doctor E. Zatarain-Nicolas (Madrid, ES)

Access

Abstract

Slides

Access the full session

Decoding cardiac biomarkers and coronary interventions in patients with cancer

Speakers: Doctor I. Nardi Agmon, Doctor J. Sodling, Doctor L. Spadafora, Doctor Y. Shibutani, Doctor G. Gilbert...

Access

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources